Skip to content

Advertisement

  • Poster presentation
  • Open Access

Is the measurement of delivered dose a good performance measure? A characterization of delivered and respirable delivered dose in two brands of jet nebulizer

  • 1,
  • 1 and
  • 1
Clinical and Translational Allergy20133 (Suppl 1) :P10

https://doi.org/10.1186/2045-7022-3-S1-P10

  • Published:

Keywords

  • Albuterol
  • Droplet Size Distribution
  • Fine Particle Fraction
  • Acute Severe Asthma
  • Salbutamol Sulphate

Background

Use of a nebulizer facilitates rapid administration of high doses of drug, which is desirable for patients presenting with acute severe asthma. Breath-enhanced jet nebulizers direct the patient s air flow through the nebulizer handset during inhalation producing aerosol output with a more favorable respirable profile. SideStream Plus (SS+; Philips Respironics) and Nebutech (NB; Salter Labs) are breath-enhanced jet nebulizers, designed to produce a high delivered dose in a short treatment time. A previous in vitro characterization of delivered dose and droplet size distribution of arformoterol nebulized via the SS+ and the NB indicated that the SS+ performed favorably, compared with the NB.[1] We present results of an in vitro characterization of salbutamol sulphate (albuterol sulfate) delivery via the SS+ nebulizer and the NB nebulizer.

Method

Each nebulizer was filled with 3 ml salbutamol sulphate (5 mg/2.5 ml) and run with a driving flow of 8 l/min into a CEN adult tidal breathing pattern (Vt; 500 ml, 15 BPM, I:E ratio; 1:1). The nebulizers were run in triplicate to sputter point and sputter point plus 60 s. Dose delivered to a filter (delivered dose; DD), placed between the nebulizer and breathing emulator, was quantified using high performance liquid chromatography and expressed as a µl solution equivalent. A laser diffractor (Malvern Spraytec) was used to assess fine particle fraction (FPF) and mass median diameter (MMD) after 60 s nebulization time. Fine particle dose (FPD) was calculated (FPF x delivered dose).

Results

The results are shown in Table 1

Table 1

Experimental parameter

SS+

NB

MMD (µm)

3.2

5.6

FPF (%<5 µm)

74.2

43.7

DD; Sputter (µl solution)

432

424

FPD; Sputter (µl solution)

321

185

DD; Sputter + 60 s (µl solution)

542

594

FPD; Sputter + 60 s (µl solution)

402

260

Conclusion

The total DD from the 2 nebulizers was comparable. Aerosol delivered via the SS+ nebulizer had a lower MMD and higher FPF, compared with that delivered via the NB nebulizer. This resulted in a 74% higher FPD delivered to sputter, and a 55% higher FPD delivered to sputter plus 60 s from the SS+ nebulizer compared with the NB nebulizer. The FPD represents respirable aerosol, and is therefore more clinically relevant than the DD. These results are consistent with previous work, and indicate that a high respirable dose of aerosol is produced by the SS+ nebulizer [1].

Authors’ Affiliations

(1)
Respironics Respiratory Drug Delivery (UK) Ltd, Philips Home Healthcare Solutions, UK

References

  1. Bauer A: Respir Care. 2009, 54 (10): 1342-1347.PubMedGoogle Scholar

Copyright

Advertisement